Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02432079 · ClinicalTrials.gov registry record
Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
A clinical trial of Congenital Heart Defects and Heterotaxy Syndrome, sponsored by Indiana University.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT02432079 is a study of Congenital Heart Defects and Heterotaxy Syndrome that is actively recruiting participants, run by Indiana University. The registered enrollment target is 2,000 participants, below the 10,747-participant average among 3 other Congenital Heart Defects trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02432079, a study of Congenital Heart Defects and Heterotaxy Syndrome, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to obtain specimens and data from individuals and their families with heterotaxy and related congenital heart defects in order to clarify the molecular genetics of this disorder. The knowledge gained from the analysis of this information will provide the basis for future genetic counseling as well as contribute to knowledge about the biology of normal and abnormal development of left-right anatomic asymmetry.
Conditions Studied
Study Locations (1)
Indiana
- Indiana University School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2009-07 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02432079
The ClinicalTrials.gov registry entry for NCT02432079 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,747-participant average among 3 other Congenital Heart Defects trials with a reported enrollment target (81% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Congenital Heart Defects appearing as the primary indexed condition, and to 0 interventions.
NCT02432079 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT02432079 about?
NCT02432079 is a clinical study titled "Molecular Genetics of Heterotaxy and Related Congenital Heart Defects". The goal of this study is to obtain specimens and data from individuals and their families with heterotaxy and related congenital heart defects in order to clarify the molecular genetics of this disorder. The knowledge gained from the analysis of this information will provide the basis for future ge...
What is the current status of trial NCT02432079?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2009-07. Estimated completion is 2030-12.
What conditions does trial NCT02432079 study?
This clinical trial studies the following conditions: Congenital Heart Defects, Heterotaxy Syndrome.
Who is sponsoring clinical trial NCT02432079?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02432079 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Defects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.